GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED;BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
发明人:
Maria Angelica CORTEZ,Sharareh NIKNAM,Jonathan E. SCHOENHALS,James W. WELSH,Niranjan YANAMANDRA
申请号：
US16485270
公开号：
US20190375847A1
申请日:
2018.02.13
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed herein is a method of treatment involving the combination of an anti-OX40 antigen binding protein (e.g., an anti-OX40 agonist antibody) and/or radiotherapy, for use in treating a cancer. The cancer may include anti-PD-1 resistance.
